EMA response to ECCO position statement on biosimilars
2014-01-01 Danese, S; Gomollon, F; Michetti, P
ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology
2020-01-01 Magro, Fernando; Doherty, Glen; Peyrin-Biroulet, Laurent; Svrcek, Magali; Borralho, Paula; Walsh, Alissa; Carneiro, Fatima; Rosini, Francesca; de Hertogh, Gert; Biedermann, Luc; Pouillon, Lieven; Scharl, Michael; Tripathi, Monika; Danese, Silvio; Villanacci, Vincenzo; Feakins, Roger
Unveiling role of sphingosine-1-phosphate receptor 2 as a brake of epithelial stem cell proliferation and a tumor suppressor in colorectal cancer
2020-01-01 Petti, Luciana; Rizzo, Giulia; Rubbino, Federica; Elangovan, Sudharshan; Colombo, Piergiuseppe; Restelli, Silvia; Piontini, Andrea; Arena, Vincenzo; Carvello, Michele; Romano, Barbara; Cavalleri, Tommaso; Anselmo, Achille; Ungaro, Federica; D'Alessio, Silvia; Spinelli, Antonino; Stifter, Sanja; Grizzi, Fabio; Sgambato, Alessandro; Danese, Silvio; Laghi, Luigi; Malesci, Alberto; Vetrano, Stefania
Author response to: Covid-19-related pancreatic injury
2020-01-01 Spinelli, A; Pellino, G; Danese, S
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations
2013-01-01 Van Assche, G; Dignass, A; Bokemeyer, B; Danese, S; Gionchetti, P; Moser, G; Beaugerie, L; Gomollon, F; Hauser, W; Herrlinger, K; Oldenburg, B; Panes, J; Portela, F; Rogler, G; Stein, J; Tilg, H; Travis, S; Lindsay, Jo
Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery
2020-01-01 Papa, Alfredo; Tursi, Antonio; Danese, Silvio; Rapaccini, Gianludovico; Gasbarrini, Antonio; Papa, Valerio
Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis
2018-01-01 Danese, S; D'Amico, F; Bonovas, S; Peyrin-Biroulet, L
Nonimmune cells in inflammatory bowel disease: from victim to villain
2008-01-01 Danese, S
Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease
2021-01-01 Reinisch, Walter; Gecse, Krisztina; Halfvarson, Jonas; Irving, Peter M; Jahnsen, Jørgen; Peyrin-Biroulet, Laurent; Rogler, Gerhard; Schreiber, Stefan; Danese, Silvio
Tumor necrosis factor-alpha monoclonal antibodies for Crohn's disease: Tipping the balance
2007-01-01 Danese, S; Pagano, N; Angelucci, E; Stefanelli, T; Repici, A; Omodei, P; Daperno, M; Malesci, A
High rate of Helicobacter pylori re-infection in patients affected by type 1 diabetes
2002-01-01 Ojetti, V; Pitocco, D; Bartolozzi, F; Danese, S; Migneco, A; Lupascu, A; Pola, P; Ghirlanda, G; Gasbarrini, G; Gasbarrini, A
New targeted therapies such as anti-adhesion molecules, anti-IL-12/23 and anti-Janus kinases are looking toward a more effective treatment of inflammatory bowel disease
2015-01-01 Bravata, I; Fiorino, G; Allocca, M; Repici, A; Danese, S
Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome
2013-01-01 Jovani, M; Fiorino, G; Danese, S
Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis
2015-01-01 Lichtenstein, Gr; Travis, S; Danese, S; D'Haens, G; Moro, L; Jones, R; Huang, M; Ballard, Ed; Bagin, R; Hardiman, Y; Collazo, R; Sandborn, Wj
Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use
2008-01-01 Danese, S.; Mocciaro, F.; Guidi, L.; Scribano, M. L.; Comberlato, M.; Annese, V.; Colombo, E.; Stefanelli, T.; Marzo, M.; Vangeli, M.; Pulitano', R.; Manca, A.; Armuzzi, A.; Malesci, A.; Prantera, C.; Cottone, M.
Starving the inflamed gut: Angiogenesis blockade as a novel therapeutic approach to experimental colitis
2005-01-01 Danese, S; Sans, M; Spencer, D; Beck, I; Plunkett, M; Donate, F; Campbell, M; West, G; Redline, R; Mazar, A; de la Motte, C; Gasbarrini, A; Levine, A; Fiocchi, C
New therapies for inflammatory bowel disease: from the bench to the bedside
2012-01-01 Danese, S
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study
2019-01-01 Viola, A; Monterubbianesi, R; Scalisi, G; Furfaro, F; Rea, M; Saibeni, S; Aratari, A; Bringiotti, R; Casella, G; Cantoro, L; Frankovic, I; Calella, F; Pugliese, D; Orlando, S; Samperi, L; Cappello, M; Mocci, G; Manetti, N; Annese, V; Privitera, Ac; Inserra, G; Caprioli, F; D'Inca, R; Principi, M; Papi, C; Castiglione, F; Danese, S; Ardizzone, S; Bossa, F; Kohn, A; Manguso, F; Alibrandi, A; Fiorino, G; Armuzzi, A; Fries, W
Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis
2020-01-01 Danese, Silvio; Neurath, Markus F; Kopoń, Adam; Zakko, Salam F; Simmons, Timothy C; Fogel, Ronald; Siegel, Corey A; Panaccione, Remo; Zhan, Xiaojiang; Usiskin, Keith; Chitkara, Denesh
H. pylori gastric infection in rheumatic diseases
1999-01-01 Danese, S; Gasbarrini, A; Zoli, A; Candelli, M; Franceschi, F; Ojetti, V; Armuzzi, A; Cammarota, G; Carloni, E; Cremonini, F; Gabrielli, M; Torre, Es; Zocca, Ma; Canducci, F; Magaro, M; Gasbarrini, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| EMA response to ECCO position statement on biosimilars | 1-gen-2014 | Danese, S; Gomollon, F; Michetti, P | |
| ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology | 1-gen-2020 | Magro, Fernando; Doherty, Glen; Peyrin-Biroulet, Laurent; Svrcek, Magali; Borralho, Paula; Walsh, Alissa; Carneiro, Fatima; Rosini, Francesca; de Hertogh, Gert; Biedermann, Luc; Pouillon, Lieven; Scharl, Michael; Tripathi, Monika; Danese, Silvio; Villanacci, Vincenzo; Feakins, Roger | |
| Unveiling role of sphingosine-1-phosphate receptor 2 as a brake of epithelial stem cell proliferation and a tumor suppressor in colorectal cancer | 1-gen-2020 | Petti, Luciana; Rizzo, Giulia; Rubbino, Federica; Elangovan, Sudharshan; Colombo, Piergiuseppe; Restelli, Silvia; Piontini, Andrea; Arena, Vincenzo; Carvello, Michele; Romano, Barbara; Cavalleri, Tommaso; Anselmo, Achille; Ungaro, Federica; D'Alessio, Silvia; Spinelli, Antonino; Stifter, Sanja; Grizzi, Fabio; Sgambato, Alessandro; Danese, Silvio; Laghi, Luigi; Malesci, Alberto; Vetrano, Stefania | |
| Author response to: Covid-19-related pancreatic injury | 1-gen-2020 | Spinelli, A; Pellino, G; Danese, S | |
| Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations | 1-gen-2013 | Van Assche, G; Dignass, A; Bokemeyer, B; Danese, S; Gionchetti, P; Moser, G; Beaugerie, L; Gomollon, F; Hauser, W; Herrlinger, K; Oldenburg, B; Panes, J; Portela, F; Rogler, G; Stein, J; Tilg, H; Travis, S; Lindsay, Jo | |
| Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery | 1-gen-2020 | Papa, Alfredo; Tursi, Antonio; Danese, Silvio; Rapaccini, Gianludovico; Gasbarrini, Antonio; Papa, Valerio | |
| Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis | 1-gen-2018 | Danese, S; D'Amico, F; Bonovas, S; Peyrin-Biroulet, L | |
| Nonimmune cells in inflammatory bowel disease: from victim to villain | 1-gen-2008 | Danese, S | |
| Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease | 1-gen-2021 | Reinisch, Walter; Gecse, Krisztina; Halfvarson, Jonas; Irving, Peter M; Jahnsen, Jørgen; Peyrin-Biroulet, Laurent; Rogler, Gerhard; Schreiber, Stefan; Danese, Silvio | |
| Tumor necrosis factor-alpha monoclonal antibodies for Crohn's disease: Tipping the balance | 1-gen-2007 | Danese, S; Pagano, N; Angelucci, E; Stefanelli, T; Repici, A; Omodei, P; Daperno, M; Malesci, A | |
| High rate of Helicobacter pylori re-infection in patients affected by type 1 diabetes | 1-gen-2002 | Ojetti, V; Pitocco, D; Bartolozzi, F; Danese, S; Migneco, A; Lupascu, A; Pola, P; Ghirlanda, G; Gasbarrini, G; Gasbarrini, A | |
| New targeted therapies such as anti-adhesion molecules, anti-IL-12/23 and anti-Janus kinases are looking toward a more effective treatment of inflammatory bowel disease | 1-gen-2015 | Bravata, I; Fiorino, G; Allocca, M; Repici, A; Danese, S | |
| Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome | 1-gen-2013 | Jovani, M; Fiorino, G; Danese, S | |
| Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis | 1-gen-2015 | Lichtenstein, Gr; Travis, S; Danese, S; D'Haens, G; Moro, L; Jones, R; Huang, M; Ballard, Ed; Bagin, R; Hardiman, Y; Collazo, R; Sandborn, Wj | |
| Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use | 1-gen-2008 | Danese, S.; Mocciaro, F.; Guidi, L.; Scribano, M. L.; Comberlato, M.; Annese, V.; Colombo, E.; Stefanelli, T.; Marzo, M.; Vangeli, M.; Pulitano', R.; Manca, A.; Armuzzi, A.; Malesci, A.; Prantera, C.; Cottone, M. | |
| Starving the inflamed gut: Angiogenesis blockade as a novel therapeutic approach to experimental colitis | 1-gen-2005 | Danese, S; Sans, M; Spencer, D; Beck, I; Plunkett, M; Donate, F; Campbell, M; West, G; Redline, R; Mazar, A; de la Motte, C; Gasbarrini, A; Levine, A; Fiocchi, C | |
| New therapies for inflammatory bowel disease: from the bench to the bedside | 1-gen-2012 | Danese, S | |
| Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study | 1-gen-2019 | Viola, A; Monterubbianesi, R; Scalisi, G; Furfaro, F; Rea, M; Saibeni, S; Aratari, A; Bringiotti, R; Casella, G; Cantoro, L; Frankovic, I; Calella, F; Pugliese, D; Orlando, S; Samperi, L; Cappello, M; Mocci, G; Manetti, N; Annese, V; Privitera, Ac; Inserra, G; Caprioli, F; D'Inca, R; Principi, M; Papi, C; Castiglione, F; Danese, S; Ardizzone, S; Bossa, F; Kohn, A; Manguso, F; Alibrandi, A; Fiorino, G; Armuzzi, A; Fries, W | |
| Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis | 1-gen-2020 | Danese, Silvio; Neurath, Markus F; Kopoń, Adam; Zakko, Salam F; Simmons, Timothy C; Fogel, Ronald; Siegel, Corey A; Panaccione, Remo; Zhan, Xiaojiang; Usiskin, Keith; Chitkara, Denesh | |
| H. pylori gastric infection in rheumatic diseases | 1-gen-1999 | Danese, S; Gasbarrini, A; Zoli, A; Candelli, M; Franceschi, F; Ojetti, V; Armuzzi, A; Cammarota, G; Carloni, E; Cremonini, F; Gabrielli, M; Torre, Es; Zocca, Ma; Canducci, F; Magaro, M; Gasbarrini, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista39385
Data di pubblicazione
- In corso di stampa9
- 2020 - 202711472
- 2010 - 201915948
- 2000 - 20097460
- 1990 - 19993485
- 1980 - 1989933
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.802
- Elsevier B.V.767
- John Wiley and Sons Inc524
- Springer Science and Business Med...516
- Oxford University Press483
- Lippincott Williams and Wilkins420
- Springer360
- MDPI347
- Elsevier Ltd330
- Springer Nature281
Rivista
- EUROPEAN UROLOGY529
- BLOOD372
- PLOS ONE312
- JOURNAL OF NEUROLOGY283
- EUROPEAN JOURNAL OF HEART FAILURE280
- NEUROLOGY268
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL224
- MULTIPLE SCLEROSIS216
- SCIENTIFIC REPORTS212
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19629
- Retrospective Studies628
- Treatment Outcome603
- Prognosis481
Lingua
- eng28792
- ita1958
- fre64
- und55
- spa34
- ger25
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext33605
- open3381
- reserved2292
- partially open99
- embargoed7
- mixed1